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Background. Appropriate management, including pulmonary rehabilitation, associated with correct diagnosis of chronic obstruct-
ive pulmonary disease (COPD) in patients can contribute to improving clinical conditions of these patients. Physical activity is
recommended for COPD patients. Whole-body vibration (WBV) is a modality of physical activity. Putting together the biological
effects and safe use of WBV, it may be a potentially feasible intervention to add to pulmonary rehabilitation. The purpose of this
investigation was to systematically review studies regarding the effects of WBV, as a component of the pulmonary rehabilitation, in
patients with COPD. Results. A total of six publicationsmet inclusion for review.There was evidence to support the beneficial use of
WBV to improve functional performance of the lower limbs and quality of life. However, the appropriateness of and descriptors of
WBVmethods were poorly described.Conclusions.The results of this review support the use ofWBV as a component of pulmonary
rehabilitation to assist management of patients with COPD. However, future research should examine the dose-response curve and
optimal dosing regimen of WBV according to standard reporting recommendations for people with COPD. Such an approach will
allow comparison among studies and the potential of meta-analysis of randomized controlled trials.
1. Background
Adisease of the lungs, chronic obstructive pulmonary disease
(COPD), is a preventable and/or treatable respiratory disease.
It can be characterized by progressive airflow limitation [1]
and chronic inflammatory response to noxious particles or
gases [2]. However, the progressive and incurable nature
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of COPD remains a major public health problem across
the developing and developed world [2]. The disease is a
significant contributor to global morbidity and mortality,
accounting for more than 3 million deaths in 2012 [3]. In
the United States of America alone, COPD was the third-
ranked cause of mortality, responsible for more than 120,000
annual deaths [4]. Furthermore, COPD is associated with
comorbid conditions such as skeletal muscle dysfunction and
cardiovascular diseases [5]. In addition, the severity of the
disease and associated exacerbations may require repeated
clinical evaluations, treatments, and inpatient admission [1].
Pulmonary rehabilitation can be a nonpharmacological
intervention that is part of clinical management of patients
with chronic respiratory disease who remain symptomatic or
continue to have decreased function despite standardmedical
therapy [2, 6–8]. Among people with COPD, pulmonary
rehabilitation can reduce dyspnoea and fatigue [6] and
improve peripheral skeletalmuscle function [2, 7] and quality
of life [9, 10] andmay prolong survival [11]. As a component of
pulmonary rehabilitation, physical activity is recommended
to all patients with a diagnosis of COPD and may improve
exercise tolerance and performance of activities of daily living
[2]. However, given that aerobic conditioning [12] and resis-
tance training [13] are associated with high levels of perceived
dyspnoea, fear of breathlessness can lead to reduced partici-
pation in physical activity [14, 15] and the so called dyspnoea
spiral [16]. As such, the use of peripheral muscle training
in the management of patients with COPD involves careful
consideration given the potential for exacerbations, the risk of
acute dyspnoea or hypoxemia during resistance training [13,
17], and/or aerobic conditioning [18–20]. Due to the necessity
of physical activity to theCOPDpatient and the potential lim-
itations of both aerobic conditioning and resistance training,
other modalities of exercise should be examined.
As a component of pulmonary rehabilitation, whole-
body vibration (WBV) is emerging as a potentially beneficial
modality of physical activity for people with COPD [21–
27]. Whole-body vibration has also emerged among other
populations with suboptimal health such as fibromyalgia
[28], cystic fibrosis [29–31], andmultiple sclerosis [32, 33]. As
a mode of physical activity, WBV may be performed when a
person either (a) stands stationary on a base of the platform
or (b) performs movements while standing, sitting, or lying
on an oscillating/vibratory platform such as flexion and
extension of the lower limbs [34–37]. It is speculated that the
effect of WBV on the musculoskeletal system is to produce
changes in the length-tension relationship moderated within
the muscle spindle and may elicit a tonic vibration reflex
[36, 38, 39] and subsequently improve the performance of
skeletal muscles of the lower limbs [21].
A recent systematic review of COPD and WBV aimed to
report on outcome measures of functional performance: the
6-minute walk test, the sit-to-stand test, peak knee extension
force, and quality of life [40]. Despite a small number of ran-
domized controlled trials, preliminary evidence emerged to
support the use ofWBV to improve the aforementionedmea-
sures of functional performance of people with COPD [40].
However, evidences about the specific frequency, intensity,
type, duration, and gravitational properties of the vibration
platform and WBV are yet to be described that may enhance
peripheral muscle training for people with a diagnosis of
COPD. Some recommendations by the International Society
ofMusculoskeletal andNeuronal Interactions (ISMNI) about
WBV interventions include reporting [41] (1) the vibration
device and brand, (2) direction, frequency, peak-to-peak
displacement, gravitational forces, and accuracy, and (3)
evaluation of skidding and foot position.
As evidence is supporting the beneficial use of WBV for
people with COPD [40], clinicians should be able to pre-
scribe WBV as a mode of peripheral muscle training based
on best available evidence. However, there is a total absence
of how WBV should be prescribed to improve peripheral
muscles of the lower limbs of people with COPD. Therefore,
the aim of this narrative review was to advance the seminal
work of Gloeckl et al. (2015) [40] by describing the meth-
ods of WBV exercise for people with COPD using ISMNI
recommendations and describe evidence based on National
Health and Medical Research Council hierarchy of evidence
(NHMRC, 2003–2007) [42].
2. Methods
2.1. Search Strategy. Three reviewers independently accessed
bibliographical databases through theUniversidade do Estado
do Rio de Janeiro. Searches were performed in the PubMed
(MEDLINE), Scopus, Science Direct, and PEDro databases
on February 9, 2015, each with the keywords “Chronic
obstructive pulmonary disease” OR “COPD” AND “whole-
body vibration” OR “WBV”. The review was performed with
PRISMA guidelines [43].
2.2. Inclusion and Exclusion Criteria. To be included for
review, all studies investigating effects of WBV in persons
with COPD needed to be conducted as a randomized con-
trolled trial or single group experimental studies with cross-
over designs. Only studies published in English were consid-
ered for inclusion. Studies were reviewed if they included par-
ticipants with COPD and who performed static or dynamic
exercises on a WBV platform and the method of WBV was
clearly described. Inclusion for review was based on con-
sensus among three reviewers. Data were independently
abstracted by the same three reviewers and disagreements
were resolved by majority consensus. Studies/papers were
excluded if they were review articles, replies, editorials, trial
protocols, books, or chapters.
2.3. Level of Evidence of the Selected Papers. The included
studies were classified according to the National Health and
Medical Research Council hierarchy of evidence (NHMRC,
2003–2007) [42] (see Table 1). Each article was assigned to
one reviewer and cross-checked by a second reviewer and
where therewas disagreement a third partywas consulted and
the issue discussed until consensus was reached.
3. Results
Of thousands of papers identified (see Table 2), a total of 100
were screened for review. A total of six papers met the
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Table 1: NHMRC levels of evidence relevant to the review inclusion criteria.
Level Intervention Diagnostic accuracy
I
A systematic
review/meta-
analysis of Level II
studies
A systematic review of Level II studies
II A randomizedcontrolled trial
A study of test accuracy with an independent, blinded comparison
with a valid reference standard, among consecutive persons with a
defined clinical presentation
III-1
A
pseudorandomized
controlled trial
A study of test accuracy with an independent, blinded comparison
with a valid reference standard, among nonconsecutive persons with
a defined clinical presentation
Table 2: Number of publications identified.
Search Keywords PubMed Scopus PEDro Science Direct
1 “Chronic obstructive pulmonary disease” OR “COPD” 97,248 70,969 1559 108,463
2 “Whole body vibration” OR “WBV” 1,257 2,626 167 2,738
Combined 1 and 2 16 25 5 54
Records identified through
database searching
Id
en
tifi
ca
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n
Sc
re
en
in
g
El
ig
ib
ili
ty
In
clu
de
d
Additional records identified
through other sources
Records after duplicates were removed
Records screened Records excluded
Full-text articles
assessed for eligibility
Full-text articles
excluded, with reasons
Studies included in
qualitative synthesis
Studies included in
quantitative synthesis
(meta-analysis)
(n = 0)
(n = 6)
(n = 18)(n = 24)
(n = 48)(n = 72)
(n = 72)
(n = 0)
(n = 100)
Figure 1: PRISMA flowchart.
inclusion criteria. A meta-analysis was inappropriate due to
a vast difference of intervention group and control group
interventions among the level of evidence II studies (see Fig-
ure 1).The descriptions and level of evidences of six reviewed
studies are shown in Table 3.The level of evidencewas Level II
[23, 26, 27] andLevel III-1 [22, 24, 25].Thedegree towhich the
six reviewed papers met ISMNI recommendations is shown
in Table 4.
3.1. Level of Evidence II and ISMNI Recommendations for
WBV Interventions. At this level of evidence, varying WBV
interventions improved QoL and functional performance of
the lower limbs of people with COPD [23, 26, 27]. How-
ever, the interventions varied relative to the direction of the
vibration platform, the vibration frequency, peak-to-peak
displacement, and gravitational forces (see Table 4). The
validity of each vibration platform was not established (i.e.,
frequency and displacement) nor was skidding or the posi-
tion of the feet upon the vibration platform.
3.2. Level of Evidence III-1 and ISMNI Recommendations for
WBV Interventions. At this level of evidence,WBV improved
functional performance of the lower limbs [22, 24, 25] and
QoL [22] of people with COPD (see Table 4). Two studies
met the ISMNI recommendations [24, 25]. One study did not
report vibration direction or test for accuracy and skidding.
4. Discussion
The major finding of this study was the benefit of WBV, as
a component of pulmonary rehabilitation, for people with
COPD. Specifically, evidence was found to support the use
of WBV to improve functional performance of the lower
limbs and QoL (see Table 5). The results of the current
study support the seminal work of Gloeckl et al. (2015) [40].
However, despite evidence to support the use of WBV for
people with COPD, the results of the current review revealed
that reporting WBV methods are poorly disclosed.
By accepting manufacture claims of vibration frequency
and peak-to-peak displacement rather than ascertaining
vibration parameters by using accelerometers, gravitational
forces cannot be confidently described [41]. Furthermore, if
skidding is not assessed, the parameters of the vibration study
that the participant is subjected to can no longer be defined
[Rauch]. Skidding occurs when the feet lose contact with the
vibration platform with increasing gravitational forces [34].
Only two studies of lower evidence [24, 25] could confirm
the vibration parameters for the participants with COPD. As
such, despite levels of evidence II and III-1 supporting the use
4 Evidence-Based Complementary and Alternative Medicine
Table 3: Level of evidence and outcomes of reviewed papers.
Level of evidence Authors Sample Protocols and outcome measures WBV findings
II Greulich et al.,2014 [23]
N = 40 (26 males
and 14 females)
IG n = 20
IG age = 66 ± 10
years
CG n = 20
CG age = 70 ± 10
years
IG: standard physiotherapy with
WBV
CG: standard physiotherapy
Duration: during inpatient
admission
Outcomes: CRT, 6MWT, QoL,
and serum markers
Improved CRT, 6MWT,
and QoL
Increased expression of the
TFPP receptor gamma
coactivator-1-𝛼 and levels of
irisin
Decreased serum
interleukin-8
II Pleguezuelos et al.,2013 [26]
N = 51 males
IG n = 26
IG age = 73 ± 14
years
CG n = 25
CG age = 74 ± 10
years
IG: WBV
CG: lifestyle education
Duration: 6 weeks
Outcomes: IKFET lower limb
performance, 6MWT, and
pulmonary muscular assessment
with MIP and MEP
No differences for IKFET
Improved 6MWT, MIP, and
MEP
II Gloeckl et al., 2012[27]
N = 72 (37 males
and 35 females)
IG n = 36
IG age = 64 ± 11
years
CG n = 36
CG age = 65 ± 7
years
IG: WBV with dynamic squats
CG: dynamic squats
Duration: 3 weeks
Outcomes: 6MWT, sit-to-stand
test, and QoL
Improvement in 6MWT,
sit-to-stand test
No difference between
groups for QoL
III-1 Braz Ju´nior et al.,2015 [22]
N = 11 (8 males and
3 females)
Age: 63 ± 9 years
Design: crossover
with washout
IG: WBV
CG: No intervention
Duration: 12 weeks
Outcomes: 6MWT, IPE, and QoL
Improved 6MWT and QoL
No difference among
groups for IPE
III-1 Furness et al., 2014[24]
N = 16 (12 males
and 4 females)
Age: 72 ± 9 years
Design: crossover
with washout
IG: WBV
CG: SWBV
Duration: 6 weeks
Outcomes: Borg CR-10, heart
rate, saturation of oxygen, TUG
test, 5-chair stand test, and gait
velocity
No exacerbations were
reported during the WBV
or SWBV interventions.
After improved TUG test,
5-chair stand test and gait
velocity
No meaningful difference
among groups for Borg
CR-10, heart rate, and
saturation of oxygen
III-1 Furness et al., 2013[25]
N = 17
Age: 69 ± 8 years
Design: crossover
with washout
IG: WBV
CG: SWBV
Duration: 1 session
Outcomes: Borg CR-10, heart
rate, and saturation of oxygen
No meaningful differences
among groups
IG: intervention group; CG: control group; CRT: chair rising test; 6MWT: 6-minute walk test; QoL: quality of life; IKFET: isokinetic knee flexor/extensor
testing; MIP: maximum inspiratory pressure; MEP: maximum expiratory pressure; IPE: index of perceived exertion; SWBV: sham whole-body vibration.
of WBV for people with COPD, clinicians remain without a
clear method of howWBV should be prescribed.
Whole-body vibration has been used without exacerbat-
ing peoplewithCOPD.The lowest frequency of the vibrations
generated in the platforms was about 20Hz [23]. Although
all the authors of the investigations selected in this narrative
revision [22–27] have suggested that the conditions of the
protocols arewithout problems to theCOPDpatient, it would
be interesting to use protocols with frequencies lower than
20Hz. Lower vibration frequency has been beneficially used
among patients with Parkinson’s disease with 3Hz, 6Hz, and
9Hz [44] and with fibromyalgia (12.5Hz) [28].The benefit of
lower vibration frequency for people with COPD is that the
risk of damaging fragile bone of older adultsmay bemitigated
[45]. Subsequently, the appropriateness of prescribed doses
of WBV should be at the forefront of clinicians as people
with COPD are known to have lower bone mineral density
compared with healthy matched controls [46, 47].
In general, the studies included in the current review
reported benefits without important clinical complication to
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Table 4: Descriptors of WBV based on ISMNI recommendations.
Authors Vibrationdevice
Vibration
direction
Vibration
frequency
Peak-to-peak
displacement
Gravitational
force Accuracy Skidding
Foot
position
Braz Ju´nior et
al., 2015 [22] Power Plate Not stated
35Hz
35Hz
1mm
2mm
2.46 g
4.92 g Not assessed Not assessed
200mm
apart
Greulich et
al., 2014 [23] Galileo
Side
alternating
12Hz
26Hz
26Hz
3mm
4mm
6mm
0.86 g
5.43 g
8.15 g
Not assessed Not assessed Not stated
Furness et al.,
2014 [24]
Amazing
Super
Health
Side
alternating 25Hz 2mm 2.52 g Assessed Assessed
200mm
from axis of
rotation
Furness et al.,
2013 [25]
Amazing
Super
Health
Side
alternating 25Hz 2mm 2.52 g Assessed Assessed
200mm
from axis of
rotation
Pleguezuelos
et al., 2013
[26]
Fitybe excel
pro Vertical 35Hz 4mm 9.85 g Not assessed Not assessed Not stated
Gloeckl et al.,
2012 [27] Galileo
Side
alternating
24Hz
25Hz
26Hz
6mm∗ Cannot becalculated Not assessed Not assessed Not stated
∗Peak-to-peak amplitude reported.
Table 5: Statement of evidence for WBV interventions among people with COPD.
Statement Level of evidence
WBV improves performance of field tests that simulate activities of daily living (e.g., 6MWT and
sit-to-stand test) II and III-1
WBV improves serum markers associated with COPD II
WBV may improve quality of life II and III-1
WBV does not add clinically meaningful stress on the cardiorespiratory system III-1
the patient with COPD. These findings are highly desirable
and support the use of WBV as a component of the pul-
monary rehabilitation.Whole-body vibrationwas reported as
effective and feasible interventions [27] which does not exac-
erbate perceived dyspnoea [24, 25] and may safely improve
clinical parameters of the patient with COPD [22].
5. Conclusions
The results of this review support the use of WBV as a poten-
tially important component of pulmonary rehabilitation to
assist management of patients with a diagnosis of COPD.
Furthermore,WBVhas been feasible and safely completed by
patients with COPD. However, future research should exam-
ine the dose-response curve and optimal dosing regimen
of WBV according to ISMNI recommendations for people
with COPD. Such an approach will allow comparison among
studies and the potential of meta-analysis of randomized
controlled trials.
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